2025 Event Registration Is Now Open!
We are excited to announce that our Annual GenScript Biotech Global Forum will be hosted on Jan. 15th, 2025, at the San Francisco Marriott Marquis and Online. You can join us in person or around the globe.
Register now to save your spot!
Introduction
Gene and cell therapy is booming worldwide, fueled by major innovations in life science and medicine and funding from global capital markets. To advance this crucial field, GenScript convenes top scientists and industry leaders from around the world, concurrent with the annual JP Morgan Healthcare Conference. The upcoming GenScript Biotech Global Forum 2024 will take place at the Grand Hyatt in San Francisco on Wednesday, January 10, 2024.
Under the theme Innovations and breakthroughs shaping tomorrow's cell and gene therapies, GenScript is inviting gene and cell therapy thought leaders from the research, industry, and capital communities as well as representatives from regulatory bodies to focus on recent developments in research, technological breakthroughs, commercialization challenges, and regulatory trends. We are looking forward to hosting thought leaders from around the world, united in the pursuit of cures to help more patients.
We would like to extend to you a cordial invitation to join your peers at this important event in San Francisco in January 2024.
Agenda
Registration
- Pre-registration: 50 USD /Person（before January 9, 2024）
- On-site Registration: 100 USD /Person (January 10, 2024)
- Contact us at event@genscript.com
Speakers
Konstantinos Aprilakis, M.D.
Partner
Deerfield Management
Adrian Bot, Ph.D.
CSO and EVP R&D
Capstan Therapeutics
Ray Chen, Ph.D.
President of Life Science Group
GenScript Biotech Corporation
Keith Crandell
Co-founder and Managing Director
ARCH Venture Partners
Simone Fishburn, Ph.D.
Vice President and Editor in Chief
BioCentury
Alex Goraltchouk
COO
Remedium Bio
Derek Hicks
CBO
Intellia Therapeutics
Ying Huang, Ph.D.
CEO
Legend Biotech
David Liu, Ph.D.
Professor, Investigator
Broad Institute, Harvard University, and HHMI
Nathan Mao, Ph.D.
CTO
ProBio
Peter Marks, Ph.D.
Director, Center for Biologics
Evaluation and Research
FDA
John Mendlein, Ph.D.
Executive Partner
Flagship Pioneering
Lekha Mikkilineni, Ph.D.
Assistant Professor
Stanford University School of Medicine
Ken Prentice
VP, Head of Process and Product Development
Shape Therapeutics
Stanley Qi, Ph.D.
Scientific Founder
Epic Bio
Josh Resnick, MD
Senior Managing Director
RA Capital Management
Nina Shah, M.D.
Haematology Research & Development,
AstraZeneca
Sherry Shao
Rotating CEO
GenScript Biotech Corporation
Yi Shi, Ph.D.
Founding Managing Partner
Lilly Asia Ventures
Devyn Smith, Ph.D.
CEO
Arbor Biotech
Kanti Thirumoorthy, Ph.D.
CTO (T-cell Therapy) , AstraZeneca
SVP Technical Operations, Neogene Therapeutics
Vincent Xiang, Ph.D.
Managing Partner, Founder,
7G BioVentures
Highlights of Forum
Photo Gallery of Previous Forum
Venue
Grand Hyatt San Francisco
345 Stockton St, San Francisco, CA, USA, 94108
+1 415-398-1234
https://www.hyatt.com/en-US/hotel/california/grand-hyatt-san-francisco/sfous
